Angiotensin II Type 2 Receptor Stimulation
Author(s) -
Elena Kaschina,
Aleksandra Grzesiak,
Jun Li,
Anna ForystLudwig,
M. Timm,
Franziska Rompe,
Manuela Sommerfeld,
Ulrich Rudolf Kemnitz,
Caterina Curato,
Pawel Namsolleck,
Carsten Tschöpe,
Anders Hallberg,
Mathias Alterman,
Thomas Hucko,
Ingo Paetsch,
Thore Dietrich,
Bernhard Schnackenburg,
Kristof Graf,
Björn Dahlöf,
Ulrich Kintscher,
Thomas Unger,
U. Muscha Steckelings
Publication year - 2008
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.108.784868
Subject(s) - medicine , stimulation , myocardial infarction , receptor , angiotensin ii , endocrinology , agonist , intracardiac injection , diastole , cardiology , blood pressure
This study is the first to examine the effect of direct angiotensin II type 2 (AT(2)) receptor stimulation on postinfarct cardiac function with the use of the novel nonpeptide AT(2) receptor agonist compound 21 (C21).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom